Andreas von Deimling,
Chair of the Department of Neuropathology at the University of Heidelberg
I am very delighted to welcome you to the Meeting on “Molecular Markers in Neurosurgery” at the Medical University in Vienna/Vienna General Hospital. Modern diagnosis of brain tumors using new molecular markers has revolutionized the neurosurgical field in the last years. This modern diagnosis is only possible due to the excellent cooperation with the specialists in neuropathology.
For this Meeting we have invited Andreas von Deimling, who is the Chair of the Department of Neuropathology at the University of Heidelberg. He is one of the world leading experts in the field of methylation analyses to optimize diagnosis of brain tumors.
Our Meeting will provide a great opportunity to update the knowledge in this evolving field as well as exchange ideas with specialists in this field. We invite participants from all disciplines involved and interested in the management of brain tumors.
I am looking forward to welcoming you to this Meeting at the Medical University of Vienna/Vienna General Hospital.
Head of the Department of Neurosurgery
MedUni Vienna/Vienna General Hospital